Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastases|HER2 Positive Breast
Interventions: RADIATION: 89Zr-trastuzumab|DEVICE: PET/CT scan|RADIATION: 89Zr-pertuzumab
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: United States Department of Defense|Genentech, Inc.